Read the paper at: [ Ссылка ]
Jack et al. examine the ability of plasma analytes to discriminate among amyloid and tau PET severity stages. Models with plasma analytes plus risk factors (age, sex, APOE) can discriminate among amyloid and tau PET stages with accuracy in the acceptable to excellent range. Combinations of analytes are often better than single analytes.
![](https://s2.save4k.ru/pic/NnR0kLYCBq8/maxresdefault.jpg)